SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-13-091974
Filing Date
2013-12-23
Accepted
2013-12-23 16:20:04
Documents
1
Group Members
PAOLO CAVAZZASIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.SINAF S.A.TAUFIN INTERNATIONAL S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a13-26896_1sc13da.htm SC 13D/A 313409
  Complete submission text file 0001104659-13-091974.txt   315057
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Subject) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37889 | Film No.: 131295021
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address
SIGMA TAU FINANZIARIA SPA (Filed by) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: SC 13D/A